Cargando…
Liquiritigenin Inhibits Colorectal Cancer Proliferation, Invasion, and Epithelial-to-Mesenchymal Transition by Decreasing Expression of Runt-Related Transcription Factor 2
Inhibition of tumor metastasis is one of the most important purposes in colorectal cancer (CRC) treatment. This study aimed to explore the effects of liquiritigenin, a flavonoid extracted from the roots of Glycyrrhiza uralensis Fisch, on HCT116 cell proliferation, invasion, and epithelial-to-mesench...
Autores principales: | Meng, Fan-Chun, Lin, Jun-Kai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cognizant Communication Corporation
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7848391/ https://www.ncbi.nlm.nih.gov/pubmed/29471888 http://dx.doi.org/10.3727/096504018X15185747911701 |
Ejemplares similares
-
MiR-373 Inhibits the Epithelial-Mesenchymal Transition of Prostatic Cancer via Targeting Runt-Related Transcription Factor 2
por: Pang, Jianyi, et al.
Publicado: (2021) -
Retracted: MiR-373 Inhibits the Epithelial-Mesenchymal Transition of Prostatic Cancer via Targeting Runt-Related Transcription Factor 2
por: Healthcare Engineering, Journal of
Publicado: (2023) -
Liquiritigenin Decreases Selective Molecular and Behavioral Effects of Cocaine in Rodents
por: Jang, E. Y, et al.
Publicado: (2011) -
Biotransformation of Liquiritigenin into Characteristic Metabolites by the Gut Microbiota
por: Keranmu, Adili, et al.
Publicado: (2022) -
Circ_0000799 promotes proliferation and invasion in colorectal cancer and epithelial-mesenchymal transition
por: Geng, Chang-Hui, et al.
Publicado: (2022)